TFC Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Hold
3,031
0.01% 190
2025
Q4
$154K Buy
3,031
+90
+3% +$4.6K 0.02% 151
2025
Q3
$163K Buy
2,941
+101
+4% +$5.91K 0.02% 140
2025
Q2
$196K Sell
2,840
-485
-15% -$33K 0.03% 128
2025
Q1
$231K Sell
3,325
-426
-11% -$35.2K 0.04% 110
2024
Q4
$323K Sell
3,751
-129
-3% -$13.9K 0.05% 93
2024
Q3
$462K Buy
3,880
+35
+0.9% +$4.67K 0.07% 72
2024
Q2
$549K Hold
3,845
0.1% 66
2024
Q1
$494K Sell
3,845
-195
-5% -$23.2K 0.09% 72
2023
Q4
$418K Hold
4,040
0.08% 76
2023
Q3
$367K Sell
4,040
-450
-10% -$39.6K 0.09% 74
2023
Q2
$363K Sell
4,490
-2,774
-38% -$227K 0.09% 72
2023
Q1
$578K Hold
7,264
0.15% 52
2022
Q4
$492K Hold
7,264
0.14% 59
2022
Q3
$362K Sell
7,264
-168
-2% -$9K 0.11% 63
2022
Q2
$414K Sell
7,432
-200
-3% -$11.1K 0.12% 60
2022
Q1
$424K Buy
7,632
+508
+7% +$26.1K 0.12% 61
2021
Q4
$399K Buy
7,124
+850
+14% +$46K 0.12% 66
2021
Q3
$301K Buy
6,274
+310
+5% +$15K 0.1% 75
2021
Q2
$250K Buy
5,964
+116
+2% +$4.5K 0.09% 81
2021
Q1
$197K Sell
5,848
-136
-2% -$4.84K 0.08% 87
2020
Q4
$209K Buy
5,984
+592
+11% +$20.5K 0.09% 82
2020
Q3
$187K Buy
+5,392
New +$180K 0.09% 78

Other funds holding NVO

TFC Financial Management's NVO Position: Q1 2026 in Review

TFC Financial Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 3,031 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #190.

TFC Financial Management first reported a position in NVO in Q3 2020 and has held it in 23 quarters since. The position peaked at $578K in Q1 2023. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • TFC Financial Management held 3,031 shares of Novo Nordisk worth $111K as of Q1 2026.
  • TFC Financial Management left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.01% of TFC Financial Management's portfolio in Q1 2026, its #190 holding.
  • TFC Financial Management first reported a position in Novo Nordisk in Q3 2020 and has held it in 23 quarters since.
  • TFC Financial Management's Novo Nordisk position peaked at $578K in Q1 2023.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.